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Introduction
Since Rudolph Virchow’s initial description of the term
“amyloid” in 1854, amyloidosis has become recognized
as a group of disorders resulting from extracellular tis-
sue deposition of fibrils comprised of low-molecular-
weight subunits of a variety of proteins.1 En route to
fibrillogenesis, misfolding of proteins occurs, which
converts soluble precursor proteins into insoluble poly-
meric amyloid fibrils. Several unique staining patterns
have been discovered as a result of the adoption of
antiparallel beta-pleated sheet conformation.2 An apple-
green birefringence can be displayed under polarized
light after staining with Congo red and an intense 
yellow-green fluorescence is demonstrated with the
use of thioflavin T.
Clinically, amyloidosis can manifest in several dif-
ferent forms: primary versus secondary, heredofamilial
versus acquired, and generalized versus localized. The
most frequent types encountered in clinical practice are
the amyloid light chain (AL, primary) and a protein
called the AA protein (secondary), both of which might
involve multiple organ systems (e.g. kidney, heart,
and liver). Isolated deposition of fibrillar proteins in
an organ may result in organ-specific syndromes (e.g.
Alzheimer’s disease and primary localized amyloidosis
of the bladder).3 In the head and neck region, the
most common site of amyloid depositions is in the
larynx, and other sites include the orbit, skin, tongue,
salivary glands and cervical lymph nodes.4 Localized
nasopharyngeal amyloidosis is an extremely rare con-
dition, and few cases have been reported.5
Compared with the USA and Western European
countries, nasopharyngeal carcinoma is endemic in
some countries of Southeast Asia. Consequently, when
a nasopharyngeal mass is visualized at otolaryngologic
clinics in Taiwan, nasopharyngeal carcinoma should be
the first priority to be considered, especially in adult
populations.
We report an unusual case of amyloidosis localized
to the nasopharynx, which was an unexpected diag-
nostic finding, following biopsy of the nasopharyngeal
mass. We also review the literature regarding its patho-
genesis, clinical manifestations, diagnostic methods
and management options.
Case Report
An 86-year-old man presented to our department
with the chief complaint of intermittent postnasal
drip for several years. His past medical history was as
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follows: (1) duodenal ulcer; (2) drug-induced hepatitis;
(3) allergic rhinitis; and (4) bilateral sensorineural hear-
ing loss. Initially, he did not pay much attention to the
postnasal drip. There were no associated symptoms 
of epistaxis, persistent nasal obstruction, facial pain or
visual change. He denied smoking and drinking alcohol.
The family history was noncontributory.
On physical examination of our patient, no obvious
neck mass was palpated. Nasal endoscopy revealed an
irregular, yellowish-colored, smooth-surfaced bulging
at the left aspect of the nasopharynx (Figure 1A).
Bilateral intact eardrums with good mobility were
found on pneumatic otoscopy. Pure tone audiometry
showed nearly symmetric sensorineural hearing loss
bilaterally. Otherwise, there were no remarkable findings
in other parts of the body.
Under the tentative diagnosis of suspected naso-
pharyngeal malignancy, nasopharyngeal biopsy was
undertaken. However, pathological analysis showed
squamous and respiratory mucosal tissue with infiltra-
tion of inflammatory cells and deposition of globules
of a pink-colored amyloid substance in subepithelial
connective tissue (Figure 2A). The amyloid substance
stained a red color with Congo red solution and gave
apple-green birefringence under polarized light (Figure
2B). There was no evidence of malignancy in this
biopsied specimen.
On admission, chest X-ray showed nonspecific
interstitial infiltration in both lung fields. Magnetic
resonance imaging (MRI) demonstrated a hypointense
submucosal soft-tissue mass on the left aspect of 
the nasopharyngeal wall with local extension to the oro-
pharynx on a T2-weighted sequence, and showed slight
enhancement on a postcontrast T1-weighted sequence
(Figure 3). Sonography of the abdomen disclosed no
significant findings. To exclude systemic amyloidosis,
anterior abdominal wall fat pad biopsy was conducted,
and no pathological process was identified. As a result,
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Figure 1. (A) Nasal endoscopy shows a heterogeneously reddish, smooth-surfaced exophytic tumor in the nasopharynx. (B) The lesion
remained in place without progression over the 3-year follow-up period.
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Figure 2. (A) Routine light microscopy shows deposition of lobules of an eosinophilic amorphous substance with encasement of blood
vessels in submucosal connective tissue (hematoxylin & eosin, 25×). (B) Polarized-light microscopy shows the amorphous substance
with an apple-green birefringence after staining with Congo red (25×).
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under the final diagnosis of localized amyloidosis of
the nasopharynx, this patient has undergone regular
follow-up at our outpatient clinic for more than 3
years without progression of local disease (Figure 1B)
or development of systemic symptoms.
Discussion
Amyloidosis refers to diseases characterized by extra-
cellular eosinophilic deposition of insoluble polymeric
fibrillar proteins in tissues and organs. More than 25
distinct biochemical forms of precursor proteins have
been identified, many of which circulate as constituents
of plasma. Fibril formation is also associated with code-
position of nonfibrillar substances including proteo-
glycans, glycoprotein, serum amyloid P-component,
and apolipoprotein E. Clinically, amyloidosis can be
categorized as primary, when associated with plasma
cell dyscrasia, or secondary, when occurring as a com-
plication of an underlying disease in which there is
ongoing or recurrent inflammation.6 Heredofamilial
amyloidoses comprise a heterogeneous group of dom-
inantly inherited disorders with several distinct pat-
terns of organ involvement. Amyloidosis of the upper
aerodigestive tract generally behaves as a benign,
localized condition, with the larynx being the most
common site of amyloid deposition.4 The majority of
patients with head and neck amyloidosis have no
underlying chronic systemic disease (i.e. primary
form). Nasal or nasopharyngeal amyloidosis is a very
rare condition with few case reports seen in the English
scientific literature. Both sexes may be affected, with a
great variation in age of disease onset (8–86 years old).
The presenting symptoms consist of nasal obstruc-
tion, recurrent epistaxis, postnasal drip and ear problems
due to eustachian tube obstruction with resultant
middle ear effusion.7 Occasionally, it may manifest as 
a clinical picture simulating an apparent malignancy
with cervical nodal metastasis.8 Grossly, the appearance
has been described as a yellowish or whitish polypoid,
firm mass.
The diagnosis of amyloidosis can be ascertained only
by tissue biopsy, although a detailed history and system-
atic review of clinical manifestations might be sugges-
tive of this condition. For patients with single organ
involvement, a direct biopsy on the clinically involved
site is recommended. In these patients, it is less likely
that biopsies of unaffected tissues will reveal amyloids.9
However, due to marked differences in prognosis
between systemic and localized types, it is still necessary
to differentiate by performing aspiration biopsy of sub-
cutaneous fat, or a rectal biopsy. The amyloid deposits
appear as amorphous hyaline material on light micros-
copy. On Congo red staining, green birefringence is
revealed under polarized light, and electron microscopy
shows 8–10-nm wide, straight, and unbranching fibrils.
There are no specific features on imaging studies
of nasopharyngeal amyloidosis. Usually, computed
tomography and/or MRI are performed. Computed
tomography scans demonstrate focal amyloidosis as a
well-defined, submucosal, homogeneous, hyperdense,
soft tissue mass in association with calcifications.10
Following administration of a contrast agent, the lesion
exhibits slight or no enhancement. A “fluffy” appear-
ance of bones surrounding the lesion has been shown,
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Figure 3. (A) Axial T2-weighted magnetic resonance imaging shows a hypointense, submucosal soft-tissue mass in the nasopharynx
(arrow). (B) Axial gadolinium-enhanced T1-weighted magnetic resonance imaging shows heterogeneous enhancement of the lesion,
mainly at the left aspect of the nasopharynx (arrow).
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which is thought to result from an osteoblastic reac-
tion provoked by submucosal deposition of amyloid
fibrils.11 MRI studies show a submucosal mass with low
signal intensity in both T1- and T2-weighted images,
and mild enhancement in postcontrast T1-weighted
images. However, Motosugi et al reported a case of
localized nasopharyngeal amyloidosis, which showed
high signal intensity on T2-weighted images and
marked early enhancement in the periphery of the mass
on dynamic contrast-enhanced MRI.12 This phenom-
enon was attributed to plasmacyte infiltration, which
occasionally occurs with amyloidosis, leading to
hypervascularity.
Currently, there is no universally effective, specific
therapy for systemic amyloidosis. Treatment generally
varies with different types of amyloidosis and is aimed
at the underlying primary disorders. It has previously
been shown that regression of symptoms can occur as
well as a decrease in amyloid burden following success-
ful treatment of underlying disorders.13 For localized
amyloidosis of the nasopharynx, surgical resection is
usually chosen as the treatment modality for symptom-
atic relief. However, the extent of surgical excision
has changed from radical excision to a more conserva-
tive approach. The rationale behind this alteration is
that a conservative surgical approach may be associated
with a slower rate of recurrence.14 Unfortunately, failure
to prevent recurrence by means of surgical excision has
been found in the majority of case reports. Simpson
et al have suggested a reduction in the recurrence 
rate following laser resection.15 Emerging treatment ap-
proaches employing agents that disrupt fibril formation,
destabilize amyloid deposits, or interfere with interac-
tion between amyloidogenic proteins and accessory
molecules have shown promising results in animal models,
and clinical applications are underway.16 Currently,
there are no reports showing progression of localized
amyloidosis to the systemic form. In addition, a sur-
vival benefit from surgical excision of nasopharyngeal
amyloidosis has not been demonstrated. Finally, com-
plete removal of amyloid tumors in the nasopharynx
may greatly impair normal physiological functions.
For the above reasons, careful observation with regular
follow-up by nasal endoscopy and imaging studies is a
reasonable therapeutic option.
In conclusion, amyloidosis is a rarely encountered
entity in the nasopharyngeal region. Most cases of
amyloidosis manifest initially as nonspecific symptoms
and signs. A definitive diagnosis can be established 
via biopsy with adequate pathological analysis. Radio-
graphical studies can aid in delineating the local extent
of disease and observation alone can be instituted
safely in selected patients.
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